aspirin

1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.

1. Antipyretic and analgesic, 0.3-0.6g once, 3 times a day, once every 4 hours if necessary. 2. Anti-rheumatic, 3-5g a day (7-8g can be used for acute rheumatic fever), divided into 4 doses for oral administration. 3. Inhibit platelet aggregation, there is no clear dosage, most advocate the use of small doses, such as 50-150mg, once every 24 hours. 4. Treat biliary ascariasis, 1g once, 2-3 times a day, for 2-3 consecutive days; stop using after 24 hours of paroxysmal colic, and then carry out anthelmintic treatment.

Gastrointestinal symptoms are the most common adverse reactions to aspirin, and the more common symptoms are nausea, vomiting, upper abdominal discomfort or pain, etc. Gastrointestinal symptoms are the most common adverse reactions to aspirin, and the more common symptoms are nausea, vomiting, upper abdominal discomfort or pain, etc.

1. Those who are allergic to aspirin, ibuprofen, naproxen, etc. 2. G6PD deficiency patients (favism) may suffer from hemolysis if they use aspirin. 3. Patients with kidney disease, gastric ulcer, diabetes, gout, etc. must consult a doctor. 4. Taking aspirin and alcohol together increases the risk of gastric bleeding. 5. Children and adolescents should not use aspirin to treat colds and flu: this is related to Reye's syndrome. 6. It has an anticoagulant effect and should not be used by hemophiliacs or other people with bleeding tendencies. 7. Pregnant women are prohibited from using aspirin.

Precautions during pregnancy and lactation: Contraindicated for use during pregnancy.

Nanjing Pharmaceutical FACTORY Co., Ltd.

• Founded in:

  1991-07-11

• Address:

  No. 26, Xingang Avenue, Nanjing Economic and Technological Development Zone

• Tax NO.:

  91320192134908655F

• Registered Funds:

  200.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view